You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 53 No. 11, November 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Early Treatment of a Single Generalized Tonic-Clonic Seizure to Prevent Recurrence

Ronit Gilad, MD; Yair Lampl, MD; Uri Gabbay, MD; Yehiel Eshel, MD; Ida Sarova-Pinhas, MD

Arch Neurol. 1996;53(11):1149-1152.


Abstract



Background
The question of whether to start antiepileptic treatment after a single unprovoked seizure remains controversial and has been the subject of much debate in the relevant literature.

Objectives
To determine the rate of recurrence of a second attack after a single unprovoked epileptic seizure by using 2 study groups of treated and untreated patients and, thus, to establish a treatment policy for these patients.

Patients and Methods
A group of 91 patients with a single generalized tonic-clonic seizure were prospectively studied; 87 of these patients completed the study. The end point of the study was 36 months after the single attack or the occurrence of a subsequent epileptic attack. The patients were randomly divided into 2 groups: 45 patients who immediately received anticonvulsive treatment and 42 who remained untreated for the follow-up period. Patients in the treated group were given monotherapy with carbamazepine. The results of recurrences were statistically analyzed by using the Kaplan-Meier method.

Results
Results indicated a significantly higher percentage of seizure-free patients in the treated group compared with that in the untreated group (P=.001). The treated men were proved to be less at risk for recurrent seizures compared with treated women (P<.001 vs P=.03, respectively).

Conclusion
Treatment after a single unprovoked seizure leads to a significant reduction in the risk of relapse of generalized tonic-clonic epilepsy.



Author Affiliations



From the Department of Neurology, The Edith Wolfson Medical Center, Holon, Israel (Drs Gilad, Lampl, Eshel, and Sarova-Pinhas); the Gerti Institute of Statistics, Sheba Medical Center, Tel Hashomer, Israel (Dr Gabbay); and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (Drs Gilad, Lampl, Eshel, and Sarova-Pinhas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence-Based Versus Reported Epilepsy Management Practices
Mastriani et al.
J Child Neurol 2008;23:507-514.
ABSTRACT  

Optimizing therapy of seizures in stroke patients
Ryvlin et al.
Neurology 2006;67:S3-S9.
ABSTRACT | FULL TEXT  

Recent Advances in the Treatment of Epilepsy
Nguyen and Spencer
Arch Neurol 2003;60:929-935.
FULL TEXT  

EFFICACY OF TREATMENT AFTER A SINGLE SEIZURE
JWatch General 1996;1996:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.